×
About 37,300 results

Japan's Meiji Holdings Says Drug Unit Started Late-Stage Trial for COVID Vaccine
https://www.medscape.com/viewarticle/985469

Dec 14th, 2022 - TOKYO (Reuters) - Japan's Meiji Holdings Co said on Tuesday its drug subsidiary had started a Phase III trial of an mRNA-based vaccine for COVID-19. Meiji Seika Pharma had started the late-stage trial among 780 subjects in Japan, with the test period running from November to April 2024, Meiji said in a statement. The trial will test the effectiveness of the vaccine, developed by U.S.-based Arct...

China Stops Publishing Asymptomatic COVID Cases, Reports No Deaths
https://www.medscape.com/viewarticle/985545

Dec 14th, 2022 - BEIJING (Reuters) -China's National Health Commission (NHC) will as of Wednesday stop reporting new asymptomatic COVID-19 infections, as many people without symptoms no longer participate in testing, making it hard to accurately tally the total count, it said. The health authority reported 2,291 new symptomatic COVID-19 infections on Dec. 13. China recorded 7,679 new cases a day earlier – 2,315...

DeSantis Seeks Grand Jury Investigation of COVID-19 Vaccines
https://www.medscape.com/viewarticle/985572

Dec 14th, 2022 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. MIAMI (AP) — Florida Gov. Ron DeSantis said Tuesday that he plans to petition the state's Supreme Court to convene a grand jury to investigate "any and all wrongdoing" with respect to the COVID-19 vaccines. The Republican governor, who is often mentioned as a possible presidential candidate in 2...

Infectious Disease Fellowship Matches Nose-dive After Pandemic Bump
https://www.medscape.com/viewarticle/985587

Dec 14th, 2022 - Just 56% of infectious disease fellowship programs filled their 2023 slots, according to new data released by the National Resident Matching Program. Infectious disease (ID) fellowships had seen a jump in applications in the previous 2 years, but these new numbers may suggest a backward slide in a specialty that for many years has struggled to recruit residents. This latest match rate in ID fel...

Shionogi Says Japan Government to Buy 1 Million More COVID Pill Doses
https://www.medscape.com/viewarticle/985468

Dec 14th, 2022 - TOKYO (Reuters) - Shionogi & Co Ltd said on Tuesday the Japanese government agreed to purchase an additional 1 million doses of its oral treatment for COVID-19. Shionogi previously agreed to sell a million doses of the drug, a protease inhibitor known as ensitrelvir and commercially as Xocova, to the government pending approval. The added supply agreement comes at a time when Japan is dealing w...

Pfizer Says It Is Working to Improve Supply of COVID Drug Paxlovid in China
https://www.medscape.com/viewarticle/985510

Dec 14th, 2022 - (Reuters) - Drugmaker Pfizer Inc said on Tuesday it is working to improve supply of its COVID-19 antiviral drug Paxlovid in China in order to ensure adequate access to the drug as cases rise in the country. "Pfizer is actively collaborating with all stakeholders to secure an adequate supply of Paxlovid in China and remains committed to fulfilling the COVID-19 treatment needs of patients in Chin...

China to Roll Out Second COVID Vaccine Booster for High-Risk Groups, Elderly
https://www.medscape.com/viewarticle/985546

Dec 14th, 2022 - BEIJING (Reuters) - China's National Health Commission (NHC) will roll out the second COVID-19 vaccine booster shots for high-risk groups and elderly people over 60 years old, it said in a statement on Wednesday. The time gap between the first and second booster shots will be six months, NHC said, adding people who can take the second booster shot will include those with severe existing disease...

Happy 200th Birthday, Gregor Mendel and Louis Pasteur
https://www.medscape.com/viewarticle/985304

Dec 13th, 2022 - Louis Pasteur December 27 marks the 200th birthday of Louis Pasteur (1822-1895), the scientist who advanced microbiology and vaccinology and was a main figure bringing germ theory to the forefront of medicine. Earlier in the year, July 20, we also celebrated the 200th birthday of Gregor Mendel (1822-1884), whose contribution — genetics — went unnoticed in his time but is central to modern medic...

China Re-opens More Areas at Risk for COVID Spread as Lockdowns Ease
https://www.medscape.com/viewarticle/985392

Dec 13th, 2022 - BEIJING (Reuters) - China has slashed the number of locations deemed at high risk of wider COVID outbreaks, re-opening locked down areas including one hosting a key factory of an Apple supplier. The number of high-risk areas tumbled to around 4,500 on Monday, official data showed, down 85% from more than 30,000 on Dec. 7 before the latest policy shift was announced. A district in the city of Zh...

China COVID Infection Fears Fuel Medical Stock Bets
https://www.medscape.com/viewarticle/985387

Dec 13th, 2022 - SHANGHAI (Reuters) - Investors snapped up shares of Chinese drugmakers, mask producers, antigen test companies and funeral service providers on Monday, amid fears of soaring mass infections following China's pivot away from strict zero-COVID policies last week. Medical supplies producers are being bombarded with questions from investors about their capacity, after authorities on Wednesday annou...

Macau to Allow Home Isolation for COVID Infections
https://www.medscape.com/viewarticle/985388

Dec 13th, 2022 - HONG KONG (Reuters) - Macau's government will allow people infected with COVID-19 to isolate at home from Wednesday, a key step towards relaxing strict virus control measures in the world's gambling hub for the first time in almost three years. Health officials said that infected patients would be able to stay at home and self-monitor for five days. This would help to reduce pressure on medical...

Nigeria Scraps COVID-19 Tests for International Travelers
https://www.medscape.com/viewarticle/985436

Dec 13th, 2022 - LAGOS (Reuters) - Nigeria on Monday removed COVID-19 testing requirements for international travelers and it was no longer mandatory to wear masks on flights and inside airport buildings, the airlines regulator said. In a notice to airlines, the Nigerian Civil Aviation Authority said travelers to and from Nigeria did not need to undergo COVID-19 irrespective of their vaccination status. The aut...

Over 50% of COVID Preprints Later Published in Peer-Reviewed Journals
https://www.medscape.com/viewarticle/985481

Dec 13th, 2022 - More than 50% of COVID-19 studies first published on the preprint server medRxiv were published in peer-reviewed journals within two years, according to a research letter published recently on JAMA Open Network. In March 2022, European researchers looked at all COVID preprints posted on medRxiv during 2020. Of the 3,343 preprints on COVID posted that year, 1,712 (51.2%) were published in peer-r...

As Old COVID Drugs Fail, New Ones Unclear; Problems With Canada's Prison Needle Exchange; and New CMS Rule to Speed Up OKs
https://www.medscape.com/viewarticle/985359

Dec 13th, 2022 - As Old COVID Drugs Fail, New Ones Unclear Old COVID-19 treatments are losing effectiveness, but it's unclear whether pharma companies will develop new ones because of their cost and short lifespans. Monoclonal antibody treatments have lost potency as the coronavirus has mutated. Antiviral drugs, including Paxlovid, remain available but are underused. Convalescent plasma, a treatment used early ...

Queues Form at Fever Clinics as China Wrestles With COVID Surge
https://www.medscape.com/viewarticle/985389

Dec 13th, 2022 - BEIJING/HONG KONG (Reuters) - People queued outside fever clinics at Chinese hospitals for COVID-19 checks on Monday, a new sign of the rapid spread of symptoms after authorities began dismantling an apparatus they used to surveil residents and curtail movement. Three years into the pandemic, China is now acting to align with a world that has largely reopened to live with COVID, after unprecede...

Mexican State Brings Back Mask Mandate as COVID Numbers Rise
https://www.medscape.com/viewarticle/985434

Dec 13th, 2022 - MEXICO CITY (Reuters) - A northern Mexican state reintroduced the obligatory use of face masks in closed public spaces, officials said on Monday, in a bid to reduce rising COVID-19 infections, as well as the spread of other respiratory diseases. The health minister of Nuevo Leon state, home to Mexico's third-biggest city Monterrey, highlighted the updated guidelines in a news conference, and sa...

Cancer Patients Struggle to Access Psilocybin Before They Die
https://www.medscape.com/viewarticle/985501

Dec 13th, 2022 - In March 2020, when the world was struck by the news of the COVID-19 pandemic, Erinn Baldeschwiler received her own gut punch. She was diagnosed with stage IV metastatic breast cancer and was given about 2 years to live. Then 48, the mother of two teenagers had just started a new chapter in her life. She'd gotten divorced, moved to a new home, and left a small business she had spent 18 years cu...

COVID Vaccines Saved More Than 3 Million US Lives Since 2020
https://www.medscape.com/viewarticle/985529

Dec 13th, 2022 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. COVID-19 vaccinations prevented 3.2 million deaths and 18.5 million hospitalizations in the United States from December 2020 through November 2022, according to a new report Tuesday from the Commonwealth Fund and Yale School of Public Health. The report, developed from computer modeling, comes a...

Canada Authorizes First Bivalent Booster Shot for 5- to 11-Year-Olds
https://www.medscape.com/viewarticle/985336

Dec 12th, 2022 - OTTAWA (Reuters) - Canada on Friday authorized Pfizer-BioNTech's bivalent COVID-19 vaccine booster for children 5 to 11 years of age, according to statement from Health Canada. Pfizer-BioNTech's shots are designed to target the BA.4/BA.5 variants of Omicron as well as the original coronavirus variant, and is the first bivalent booster authorized in Canada for 5- to 11-years age group, Health Ca...

T2D Diagnoses Spike Coincident With COVID Onset
https://www.medscape.com/viewarticle/985401

Dec 12th, 2022 - Researchers published the study covered in this summary on medRxiv as a preprint that has not yet been peer reviewed. Key Takeaways A sharp spike in new diagnoses of type 2 diabetes occurred starting 7 days before and continuing for 30 days after onset of infection with COVID-19 (SARS-CoV-2), followed by a decrease in new diagnoses of diabetes out to a year later, in a study of data from a larg...